The Current Ratio as of December 2025 (TTM) for Zydus Lifesciences Limited (ZYDUSLIFE.NS) is 1.94

According to Zydus Lifesciences Limited’s latest financial reports and current stock price. The company's current Current Ratio is 1.94. This represents a change of 102.78% compared to the average of 0.96 of the last 4 quarters.

Zydus Lifesciences Limited (ZYDUSLIFE.NS) Historical Current Ratio (quarterly & annually)

How has ZYDUSLIFE.NS Current Ratio performed in the past?

The mean historical Current Ratio of Zydus Lifesciences Limited over the last ten years is 1.45. The current 1.94 Current Ratio has changed 13.26% with respect to the historical average. Over the past ten years (40 quarters), ZYDUSLIFE.NS's Current Ratio was at its highest in in the September 2023 quarter at 2.28. The Current Ratio was at its lowest in in the December 2015 quarter at 0.

Zydus Lifesciences Limited (ZYDUSLIFE.NS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Zydus Lifesciences Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Zydus Lifesciences Limited (ZYDUSLIFE.NS) Average Current Ratio

How has ZYDUSLIFE.NS Current Ratio performed in the past?

The current Current Ratio of Zydus Lifesciences Limited (ZYDUSLIFE.NS) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Zydus Lifesciences Limited (ZYDUSLIFE.NS) Current Ratio vs. Peers

How is ZYDUSLIFE.NS’s Current Ratio compared to its peers?

Zydus Lifesciences Limited’s Current Ratio is greater than Dr. Reddy's Laboratories Limited (1.85), greater than Dr. Reddy's Laboratories Limited (1.85), greater than Lupin Limited (1.87), greater than Mankind Pharma Limited (1.14), greater than Mankind Pharma Limited (1.14), greater than Lupin Limited (1.87), greater than Aurobindo Pharma Limited (1.85), greater than Aurobindo Pharma Limited (1.85), less than Alkem Laboratories Limited (2.49), less than Alkem Laboratories Limited (2.49),

Build a custom stock screener for Zydus Lifesciences Limited (ZYDUSLIFE.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zydus Lifesciences Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zydus Lifesciences Limited (ZYDUSLIFE.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zydus Lifesciences Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.